Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Structure-Activity Relationship Studies of a Series of Semisynthetic Lipopeptides Leading to the Discovery of Surotomycin, a Novel Cyclic Lipopeptide Being Developed for the Treatment of Clostridium difficile-Associated Diarrhea.

Yin N, Li J, He Y, Herradura P, Pearson A, Mesleh MF, Mascio CT, Howland K, Steenbergen J, Thorne GM, Citron D, Van Praagh AD, Mortin LI, Keith D, Silverman J, Metcalf C.

J Med Chem. 2015 Jun 25;58(12):5137-42. doi: 10.1021/acs.jmedchem.5b00366. Epub 2015 Jun 3.

PMID:
25993059
2.

Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies.

Steenbergen JN, Mohr JF, Thorne GM.

J Antimicrob Chemother. 2009 Dec;64(6):1130-8. doi: 10.1093/jac/dkp346. Epub 2009 Oct 12. Review.

PMID:
19825818
3.

Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia.

Pertel PE, Bernardo P, Fogarty C, Matthews P, Northland R, Benvenuto M, Thorne GM, Luperchio SA, Arbeit RD, Alder J.

Clin Infect Dis. 2008 Apr 15;46(8):1142-51. doi: 10.1086/533441.

PMID:
18444848
4.

Detection of daptomycin-nonsusceptible strains using the Neo-Sensitab prediffusion method.

Katz BD, Luperchio SA, Thorne GM.

Diagn Microbiol Infect Dis. 2008 Jul;61(3):315-20. doi: 10.1016/j.diagmicrobio.2008.01.021. Epub 2008 Mar 12.

PMID:
18339508
5.

In vitro activity of daptomycin against multidrug-resistant Staphylococcus aureus and S. aureus with known virulence factors, including community-acquired methicillin-resistant isolates.

Anastasiou DM, Morgan M, Ruane PJ, Steenbergen JN, Katz BD, Alder JD, Thorne GM.

Diagn Microbiol Infect Dis. 2008 Jul;61(3):339-42. doi: 10.1016/j.diagmicrobio.2008.01.012. Epub 2008 Mar 4.

PMID:
18304772
6.

In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin.

Anastasiou DM, Thorne GM, Luperchio SA, Alder JD.

Int J Antimicrob Agents. 2006 Nov;28(5):385-8. Review.

PMID:
17046205
7.

Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates.

Jevitt LA, Thorne GM, Traczewski MM, Jones RN, McGowan JE Jr, Tenover FC, Brown SD.

J Clin Microbiol. 2006 Sep;44(9):3098-104.

8.

Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis.

Streit JM, Steenbergen JN, Thorne GM, Alder J, Jones RN.

J Antimicrob Chemother. 2005 Apr;55(4):574-8. Epub 2005 Feb 18.

PMID:
15722390
9.

Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.

Steenbergen JN, Alder J, Thorne GM, Tally FP.

J Antimicrob Chemother. 2005 Mar;55(3):283-8. Epub 2005 Feb 10. Review.

PMID:
15705644
10.

Engineering vitamin E content: from Arabidopsis mutant to soy oil.

Van Eenennaam AL, Lincoln K, Durrett TP, Valentin HE, Shewmaker CK, Thorne GM, Jiang J, Baszis SR, Levering CK, Aasen ED, Hao M, Stein JC, Norris SR, Last RL.

Plant Cell. 2003 Dec;15(12):3007-19. Epub 2003 Nov 20.

11.

Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein.

Levy O, Martin S, Eichenwald E, Ganz T, Valore E, Carroll SF, Lee K, Goldmann D, Thorne GM.

Pediatrics. 1999 Dec;104(6):1327-33.

PMID:
10585984
12.

PHA production, from bacteria to plants.

Valentin HE, Broyles DL, Casagrande LA, Colburn SM, Creely WL, DeLaquil PA, Felton HM, Gonzalez KA, Houmiel KL, Lutke K, Mahadeo DA, Mitsky TA, Padgette SR, Reiser SE, Slater S, Stark DM, Stock RT, Stone DA, Taylor NB, Thorne GM, Tran M, Gruys KJ.

Int J Biol Macromol. 1999 Jun-Jul;25(1-3):303-6.

PMID:
10416678
13.

Parvovirus B19-associated interstitial lung disease, hepatitis, and myositis.

Bousvaros A, Sundel R, Thorne GM, McIntosh K, Cohen M, Erdman DD, Perez-Atayde A, Finkel TH, Colin AA.

Pediatr Pulmonol. 1998 Nov;26(5):365-9. Review. No abstract available.

PMID:
9859908
14.

Immune response to Escherichia coli O157:H7 in hemolytic uremic syndrome following salmonellosis.

Flores FX, Jabs K, Thorne GM, Jaeger J, Linshaw MA, Somers MJ.

Pediatr Nephrol. 1997 Aug;11(4):488-90.

PMID:
9260252
15.

Chronic parvovirus B19 infection resulting in chronic fatigue syndrome: case history and review.

Jacobson SK, Daly JS, Thorne GM, McIntosh K.

Clin Infect Dis. 1997 Jun;24(6):1048-51.

PMID:
9195056
16.

Neonatal herpes simplex virus infection presenting as fulminant liver failure.

Greenes DS, Rowitch D, Thorne GM, Perez-Atayde A, Lee FS, Goldmann D.

Pediatr Infect Dis J. 1995 Mar;14(3):242-4. No abstract available.

PMID:
7761194
17.

Primary antral gastritis in young American children. Low prevalence of Helicobacter pylori infections.

Snyder JD, Hardy SC, Thorne GM, Hirsch BZ, Antonioli DA.

Dig Dis Sci. 1994 Sep;39(9):1859-63.

PMID:
8082491
19.
20.

Multicenter evaluation of a new enzyme immunoassay for detection of Clostridium difficile enterotoxin A.

De Girolami PC, Hanff PA, Eichelberger K, Longhi L, Teresa H, Pratt J, Cheng A, Letourneau JM, Thorne GM.

J Clin Microbiol. 1992 May;30(5):1085-8.

21.
22.
23.

Microbial challenge of a blood cell separator outside-seal bowl system.

Jacobson MS, Kevy SV, Thorne GM, Goldmann DA, Blasetti L, Smith JW, Schaefer H.

Transfusion. 1990 Feb;30(2):146-9.

PMID:
2407000
25.

Diagnosis of infectious diarrheal diseases.

Thorne GM.

Infect Dis Clin North Am. 1988 Sep;2(3):747-74. Review.

PMID:
3074126
26.

Performance of a solid phase enzyme immunoassay for detection of group A streptococci in a pediatric office laboratory as refereed by a hospital laboratory.

Yuckienuz SA, Thorne GM, Macone AB, Goldmann DA, St Pierre J, Marcus EP.

Pediatr Infect Dis J. 1988 Jun;7(6):393-8.

PMID:
3292998
27.

Evaluation of a latex agglutination test for diagnosis of Clostridium difficile-associated colitis.

Sherman ME, DeGirolami PC, Thorne GM, Kimber J, Eichelberger K.

Am J Clin Pathol. 1988 Feb;89(2):228-33.

PMID:
3341282
28.

Mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in the granuloma pouch assay.

Radermacher J, Thorne GM, Goldin BR, Sullivan CE, Gorbach SL.

Mutat Res. 1987 Feb;187(2):99-103.

PMID:
3807940
29.

Gastrointestinal infections--dietary interactions.

Thorne GM.

J Am Coll Nutr. 1986;5(5):487-99. Review.

PMID:
3537076
30.

Effect of tetracycline on the attachment of K88+ enterotoxigenic Escherichia coli to porcine small-intestinal cells.

Deneke CF, Thorne GM, Larson AD, Gorbach SL.

J Infect Dis. 1985 Nov;152(5):1032-6.

PMID:
3900235
31.

A novel strain of Escherichia coli causing diarrhea, bacteremia, and fever in a human.

Thorne GM, Rothman SW, Gorbach SL.

J Infect Dis. 1985 May;151(5):960-3. No abstract available.

PMID:
2859340
32.

Attachment of enterotoxigenic Escherichia coli to human intestinal cells.

Deneke CF, McGowan K, Thorne GM, Gorbach SL.

Infect Immun. 1983 Mar;39(3):1102-6.

33.

Entamoeba histolytica cytotoxin: purification, characterization, strain virulence, and protease activity.

McGowan K, Deneke CF, Thorne GM, Gorbach SL.

J Infect Dis. 1982 Nov;146(5):616-25.

PMID:
6290574
34.

Comparison of two toxins produced by Clostridium difficile.

Taylor NS, Thorne GM, Bartlett JG.

Infect Immun. 1981 Dec;34(3):1036-43.

35.

Serotypes of attachment pili of enterotoxigenic Escherichia coli isolated from humans.

Deneke CF, Thorne GM, Gorbach SL.

Infect Immun. 1981 Jun;32(3):1254-60.

36.

General characteristics: nomenclature of microbial toxins.

Thorne GM, Gorbach SL.

Pharmacol Ther. 1981;13(1):193-203. Review. No abstract available.

PMID:
7022486
37.

Attachment pili from enterotoxigenic Escherichia coli pathogenic for humans.

Deneke CF, Thorne GM, Gorbach SL.

Infect Immun. 1979 Oct;26(1):362-8.

38.

Hemagglutination and adhesiveness of toxigenic Escherichia coli isolated from humans.

Thorne GM, Deneke CF, Gorbach SL.

Infect Immun. 1979 Mar;23(3):690-9.

39.

Enterotoxigenic Escheria coli: detection and importance in diarrheal disease of children.

Thorne GM, Gorbach SL.

J Am Vet Med Assoc. 1978 Sep 1;173(5 Pt 2):592-5. No abstract available.

PMID:
359518
40.

Shigella vaccines, Shigella pathogens--Dr. Jekyll and Mr. Hyde.

Thorne GM, Gorbach SL.

J Infect Dis. 1977 Oct;136(4):601-4. No abstract available.

PMID:
908856
41.

R factor-mediated antibiotic resistance in Serratia marcescens.

Cooksey RC, Thorne GM, Farrar WE Jr.

Antimicrob Agents Chemother. 1976 Jul;10(1):123-7.

42.
43.

Transfer of ampicillin resistance between strains of Haemophilus influenzae type B.

Thorne GM, Farrar WE Jr.

J Infect Dis. 1975 Sep;132(3):276-81.

PMID:
1080495
44.

Superinfection compatibility of R factors in Shigella dysenteriae type 1 from Central America and Salmonella typhi from Mexico.

Thorne GM, Farrar WE Jr.

J Infect Dis. 1974 Sep;130(3):284-7. No abstract available.

PMID:
4607131
45.
46.

Supplemental Content

Loading ...
Support Center